Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Psoriasis 2Pruritus 1Lymphoma, Follicular 1Congenital Abnormalities 1Autoimmune Diseases 1Arthritis, Psoriatic 1

Interventions

tofacitinib 7Etanercept 7Methotrexate 4Adalimumab 4deucravacitinib 3secukinumab 2apremilast 2Nivolumab 2sotrastaurin 1sodium luminolate 1purine 1ixekizumab 1fumaric acid 1calcipotriene 1cabozantinib 1baricitinib 1abrocitinib 1Vitamin D 1Vaccines 1Sulfasalazine 1Standard of Care 1Specimen Handling 1Saline Solution 1Practice Guidelines as Topic 1Platinum Compounds 1Methods 1Mesalamine 1Mercaptopurine 1Ipilimumab 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Psoriasis × apremilast × Clear all
NCT02775500 2025-01-28

Apremilast Pregnancy Exposure Registry

University of California, San Diego

Active not recruiting
233 enrolled

Congenital Abnormalities, Autoimmune Diseases, Psoriasis, Arthritis, Psoriatic

NCT03721172 2024-05-29

ADVANCE

Amgen

Phase 3 Completed
595 enrolled 19 charts
Lymphoid

Lymphoma, Follicular, Pruritus, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡